Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, thank you for standing by and welcome to ...

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...

“We made significant progress in the third quarter, highlighted by the positive results from our first-in-human Phase 1a clinical trial of PMN310 and the closing of a strong equity financing that ...

DOWA-(MANA)-President Lazarus Chakwera has on Thursday said all Malawians, despite the areas they reside must enjoy equal access to quality health care. He was speaking at Nalunga in Dowa East ...

President-elect Donald Trump chose Rep. Matt Gaetz of Florida to serve as his attorney general on Wednesday, bypassing more experienced options in favor of a loyalist who has built a national ...